Research programme: spinal cord injury therapies - Protherics
Alternative Names: Nanotechnology therapiesLatest Information Update: 23 Nov 2009
At a glance
- Originator Protherics
- Class
- Mechanism of Action Nerve growth factor stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Spinal cord injuries
Most Recent Events
- 02 Dec 2003 Preclinical trials in Spinal cord injuries in United Kingdom (unspecified route)